Press Releases 
Press Releases - Landing Page
Peter O’Blenis to Speak at the
International Society for
Pharmacoeconomics and Outcomes Research
(ISPOR) Conference in Seoul, South
Korea, Sept. 7-9. Download PDF
TrialStat Corporation recently added
Innovaderm Research Inc. to the
growing list of CROs joining
TrialStat's CROFirst program. Download PDF
TrialStat Corporation announces its
enhanced pricing options for customers
using its ClinicalAnalytics 4.0 EDC
solution. Download PDF
TrialStat Corporation added Kriger
Research Group International, a
worldwide CRO to its enhanced CROFirst
Program. Download PDF
TrialStat Corporation added SMS-
oncology, an Amsterdam-based CRO
specializing in oncology, to its
enhanced CROFirst Program. Download PDF
TrialStat made enhancements to its
CROFirst Program to reward the
company’s CRO customers in North
America and Europe for participating
in
joint business development and
marketing of CA 4.0 to the industry. Download PDF
News
News - Landing Page
ClinPage takes a look at the need for
software used to facilitate
systematic reviews and TrialStat's SRS
4.0. More >>
ClinPage discusses Notal Vision's
premise behind its selection of
TrialStat's ClinicalAnalytics 4.0 (CA
4.0) for a Phase II Device trial. More >>
ClinPage peers under the hood of
TrialStat's ClinicalAnalytics 4.0 and
examines the company's plans to raise
the performance bar on its industry. More >>
In the December issue of eCliniqua,
Jonathan Barker, CEO and President of
TrialStat Corporation, unveils and
discusses the enhancements in the
latest release of ClinicalAnalytics
4.0. More >>
Delving into the world of Electronic
Data Capture, ClinPage examines how
TrialStat's latest version of
ClinicalAnalytics enables better EDC
reporting. More >>
